Health Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San… James Pereira Nov 29, 2023 -- Six abstracts have been accepted for presentation, including updated data on vepdegestrant alone and in combination… Read More...
Health Tessellate BIO, an Emerging Precision Oncology Company, Announces the Appointment of World-Leading… James Pereira Nov 15, 2023 AMSTERDAM and LONDON, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Tessellate BIO, a preclinical stage biotechnology company… Read More...
Health Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites James Pereira Jul 30, 2023 Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites Biodexa Pharmaceuticals PLC (NASDAQ: BDRX)… Read More...
Health Screening Kids for Lipid Disorders; Oncology Drugs for Medicare Recipients James Pereira Jul 23, 2023 TTHealthWatch is a… Read More...
Health ADC Therapeutics Announces Plan to Discontinue the Phase 2 LOTIS-9 Clinical Trial of ZYNLONTA®… James Pereira Jul 21, 2023 LAUSANNE, Switzerland, July 20, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that it… Read More...
Health Targeted Oncology™ announces recipients of its Q2 Oncology Icons award program James Pereira Jul 19, 2023 CRANBURY, N.J., July 18, 2023 (GLOBE NEWSWIRE) -- Targeted Oncology, a multimedia resource that offers engaging… Read More...
Health $76 Billion Growth for Clinical Trials Market Size to Hit 5.5% CAGR with Oncology Segment Driving… James Pereira Jul 17, 2023 Pune, India, July 17, 2023 (GLOBE NEWSWIRE) -- According to Recently Published Report by The Insight Partners,… Read More...
Health Completion of Enrolment and Treatment in the Phase 1 Study of MTX110 in the Treatment of Children… James Pereira Jul 10, 2023 10 July 2023 Biodexa Ltd(“Biodexa” or the “Company”) Completion of Enrolment and Treatment in the Phase 1 Study of… Read More...
Health CancerVAX CEO Ryan Davies Discusses Biotech Entrepreneurship with Pyxis Oncology CEO Dr. Lara… James Pereira Jul 10, 2023 LEHI, Utah, July 10, 2023 (GLOBE NEWSWIRE) -- CancerVAX, Inc., developer of a breakthrough universal cancer vaccine… Read More...